Latest News
NICE has announced that the immunotherapy nivolumab will now be made available on the Cancer Drugs Fund for treating locally advanced or metastatic squamous and non-squamous non-small-cell lung cancers after prior chemotherapy.
One of Britain’s biggest privately owned biotech companies is set to secure additional funding which could propel its progress in developing novel immunotherapies.
Handheld instrument identifies cancerous tissue during surgery, providing surgeons with accurate diagnostic information about what tissue to cut or preserve.
Journal Articles
Utilizing historical perspective methods, in this article the authors explore how clarity about the ends of engagement can inform the design of engagement efforts and lead to better outcomes; and present several lessons for improving stakeholder-engaged research.
This article reviews progress made in the creation of a transplantable artificial ovary and discusses future trends for its development.
Discover more about idiopathic thrombocytopenic purpura in this case report from Immunotherapy.
Brain and neurologic
Clinical trial reports first response of central nervous system tumor to CAR T-cells
Potential blood test shows promise for the detection of brain metastases
Genetic basis uncovered for meningioma in childhood cancer survivors
Breast
Potential blood test shows promise for the detection of brain metastases
Novel sequencing method may enable personalized combination therapy of metastatic cancer
Colorectal
MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy
Defining a strategy for oligometastic rectal cancer: an interview with Dirk Arnold
ASCO17: Global study sets risk-based standard for chemotherapy for colon cancer
Endocrine
Sonogram scoring system developed for thyroid nodules to reduce biopsy rates
Low survival rates observed for specific thyroid cancers following bone metastasis
Signaling pathways in medullary thyroid carcinoma: therapeutic implications
Gastrointestinal
Study links NF1 mutations to GIST tumors, highlighting the need for genetic testing
ESMO WCGI: Molecular changes along the upper digestive tract discovered
Genitourinary
Immunotherapy for penile cancer
European Cancer Patient Coalition's 2017 pipeline - interview with Lydia Makaroff
Gynecologic
The artificial ovary: current status and future perspectives
Ten years on: the impact of the HPV vaccine in Australia
What are the long-term benefits and harms of human papillomavirus (HPV) testing?
Head and neck
European Cancer Patient Coalition's 2017 pipeline - interview with Lydia Makaroff
AACR17: Immunotherapy efficacy may be influenced by the patient’s immune system
Hematologic
A diagnosis of lymphoma: Chris Lewis’s story
Recovery and support after a stem cell transplant: an interview with Amelia Chong
Discover overall survival data from the ENDEAVOR trial: an interview with Meletios A. Dimopoulos
Lung
Immunotherapy nivolumab given the green light by NICE for non-small cell lung cancers
OCTalks: Could nivolumab past 1 year improve progression free survival in pretreated NSCLC?
ESMO 2017: Central obesity may be a key cancer for postmenopausal women
Pancreatic
Smartphone app shows promise for pancreatic cancer detection
Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Could a blood test lead to early detection of pancreatic cancer?
Prostate
Opportunities for multiparametric MRI with PI-RADS v2 to make a difference
Further insight into AE37 peptide vaccination in prostate cancer
Multiparametric MRI of the prostate gland: technical aspects
Rare tumors
ESMO 2017: Genetic testing opens up alternative treatment options for rare cancers
Exploring treatment options for mesothelioma: an interview with Thomas John
An update on genomic-guided therapies for pediatric solid tumors
Skin
ESMO 2017: Novel clinical trial data may halt melanoma metastasis
An interview with Giuseppe Argenziano: an insight into the field of dermoscopy
Sanger Institute series: uncovering the genetics of cancer - an interview with David Adams